Revolution Medicines Prices Upsized Concurrent Offerings Of 10,563,381 Common Shares At $142 Per Share And $500M Convertible Notes For $2B Total Proceeds

Benzinga Newsdesk www.benzinga.com Neutral 63.3%

Neg 0% Neu 63.3% Pos 0%

Comments

No comments yet. Be the first!